Artrya Limited (ASX:AYA) Receives FDA Clearance for Salix® Coronary Anatomy
Artrya Limited (ASX:AYA) secures FDA clearance for Salix® Coronary Anatomy, facilitating its commercial launch in the US market.
Artrya Limited (ASX:AYA) secures FDA clearance for Salix® Coronary Anatomy, facilitating its commercial launch in the US market.
Avecho Biotechnology Limited (ASX:AVE) receives a US$3M upfront licensing fee from Sandoz AG for its CBD treatment for insomnia in Australia.
The Star Entertainment Group (ASX:SGR) confirms Sydney casino licence suspension extended until September 2025 amid ongoing remediation efforts.
SPDR S&P/ASX 200 Fund (ASX:STW) declares a final dividend of AUD 0.517934 per security for the quarter ending March 2025.
Inca Minerals Limited (ASX:ICG) halts trading pending a proposed capital raising announcement.
xReality Group Limited (ASX:XRG) enters into a debt refinancing agreement with Causeway Asset Management to strengthen its financial position and support growth.
eMetals Limited (ASX:EMT) begins soil sampling at Busia Gold Project in Uganda, targeting significant gold anomalies.
Tivan Limited (ASX:TVN) progresses joint venture with Sumitomo Corporation for the Speewah Fluorite Project, anticipating agreement execution in early April.
Incitec Pivot Limited (ASX:IPL) announces new DNEL business unit and updates on first half performance in Dyno Nobel and Fertilisers divisions.
Nimy Resources (ASX:NIM) responds to ASX query regarding recent stock surge and highlights ongoing gallium drilling and strategic collaborations.